Pulmonary sarcoidosis induced by the anti-PD-1 monoclonal antibody pembrolizumab or post-immunotherapy granulomatous reaction: which is more appropriate terminology?

---

Copy For Citation

Paydas S.

ANNALS OF ONCOLOGY, vol.27, no.8, pp.1650-1651, 2016 (SCI-Expanded)

• Publication Type: Article / Letter
• Volume: 27 Issue: 8
• Publication Date: 2016
• Doi Number: 10.1093/annonc/mdw193
• Journal Name: ANNALS OF ONCOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.1650-1651
• Çukurova University Affiliated: Yes

Abstract

Granulomatous reaction developing after immunotherapy must not be named as sarcoidosis, post-immunotherapy granulomatous reaction is more approprite in cases receiving immunotherapy.